ALTRAPHARMA Invest ApS: Financial statements 2022
CVR: 34483884
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -171,936 and a net result of DKK -484,408 compared with DKK -145,775 the year before. Equity in the 2022 report amounted to DKK 69,271. The solvency ratio was 27.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -171,936
- Profit/Loss
- DKK -484,408
- Equity
- DKK 69,271
- Total Assets
- DKK 248,911
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -172 t. | -484 t. | 69 t. | 1 |
| 2021 | - | -76 t. | -146 t. | 554 t. | 0 |
| 2020 | - | 527 t. | 407 t. | 699 t. | 0 |
| 2019 | - | 158 t. | 110 t. | 292 t. | 0 |
| 2017 | - | 473 t. | 270 t. | 517 t. | 0 |
Official annual report
Keep an eye on ALTRAPHARMA Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.